The ASCO Post

Trusted

http://www.ascopost.com/

Last activity: 05.11.2026

Active

Categories: News

The ASCO Post is a website that provides news and information about cancer research, treatment, and care. It is a reliable source of information for oncologists, hematologists, and other healthcare professionals. The website covers a wide range of topics, including immunotherapy, chemotherapy, radiation therapy, surgery, and supportive care. It also provides information about clinical trials, new drugs, and other developments in cancer research.

Twitter Email

Website visits

165.9K /mo.

Mentions

Overview

Location

United States, New York, Huntington

Employees

51-200

Mentions in press and media 29

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Jul 15, 2026	AstraZeneca Pays $600M for Oral Pill That Beat Chemo in Rare Lung Cancer	By Philip Nickell Published: Jul 15 2026, 4:46 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard
Jun 13, 2024	SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform	The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland, June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in...
May 10, 2024	Health \| Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge	The FDA conditionally approved sotorasib but required Amgen to conduct a study comparing the labeled dosage of 960 mg with a dosage of 240 mg. The trial, published in November, showed that the 960-mg dose may have given patients a month mor...
Nov 13, 2023	The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option	The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a patient in her breast cancer prevention cli...
Aug 18, 2023	Why so few get screened for lung cancer, the deadliest cancer in the U.S.	It was Thanksgiving 2021, and Michael Young was at Target buying a turkey baster. “I’m in the parking lot, and my chest starts to feel like somebody’s sitting on me,” Young recounted. But he didn’t think too much of it and waited until Febr...
Aug 9, 2023	Jobs in Oncology/Hematology	FDA is recruiting oncologists and hematologists to serve in the dynamic, highly challenging, and innovative atmosphere of oncology drug development and research. Who We Are Meet Dr. Nicole Gormley, Division Director of Hematologic Malignanc...
Jul 31, 2023	Registration Is Open for the 11th JADPRO Live, an Educational Conference for Oncology Advanced Practitioners	"We’re thrilled to welcome back our passionate community of oncology APs,” said conference chair Amy Pierre, MSN, RN, ANP-BC, of Memorial Sloan Kettering Cancer Center/Flatiron Health. “There is no question that advanced practitioners ...
Apr 21, 2023	FUJIFILM Europe launches new virtual scale solution to address challenges faced by endoscopists in polyp measurement	DÜSSELDORF, Germany, April 21, 2023 /PRNewswire/ -- A new survey of 300 endoscopists has revealed that nearly 70 percent of endoscopists agreed that the correct measurement of polyps is crucial to achieving an accurate diagnosis. This surve...
Mar 17, 2023	Accelerating Clinical Trials Through AI-Enabled Precision Oncology	Marie E. Lamont, Global RWE Data Strategy, Access & Enablement at IQVIA and General Manager The American Cancer Society’s Cancer Statistics 2023 report highlighted a few major accomplishments within oncology, such as decreased cancer mo...
Feb 27, 2023	Overall, U.S. cancer deaths continue a downward trend while prostate cancer deaths rise	The best time to find this disease is at its earliest, most treatable stage New York City prostate cancer surgeon, Dr. David Samadi, discusses findings from recent report of concerning increase in prostate cancer mortality rates Prostate ca...
Dec 12, 2022	Enterome completes patient enrollment of Phase 2 ROSALIE study evaluating its lead immunotherapy, EO2401, in recurrent glioblastoma	EO2401 is a first-in-class OncoMimics™ peptide-based immunotherapy able to rapidly activate and significantly expand existing effector memory CD8+ T cells against tumor-associated driver antigens due to their strong cross-reactivity with On...
Sep 2, 2022	People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information	I have worn many hats professionally. The most uncomfortable one is “doctor friend.” At best, it’s a request for a recommendation for a gynecologist or for advice on which antihistamine works best for allergies. But other times I have found...
Jul 21, 2022	Registration Open for the 10th JADPRO Live, an Educational Conference for Oncology Advanced Practitioners	“This conference provides not only updates on cutting-edge therapies but also a chance to explore more nuanced topics such as specialty care of the adolescent and young adult and managing cancer pain during the opioid epidemic." HUNTIN...
Jun 23, 2022	New Poster Track at JADPRO Live Announced: APSHO Patient/Advocacy Perspective	The collective voices of patients and advocacy groups, together with clinician perspectives, will provide a powerful narrative highlighting the patient journey LAWRENCEVILLE, N.J. (PRWEB) June 23, 2022 Abstract submission is now open for JA...
Jan 7, 2022	Digital health investment opportunities in 2022	At the dawn of a new year, it seems like the perfect time to reflect on what has been an exciting 12 months of investment in digital health and explore what’s next in 2022. A total of $21.3B was invested between Q1-Q3 of 2021, up from $14.6...
Jan 28, 2020	Cognitive Computing In The Next Decade Of AI	Photo:Getty
Jun 21, 2019	How to improve adoption of genetic testing into provider workflow?
May 9, 2019	BMS’s immunotherapy drug Opdivo fails in Phase III brain cancer study	Shares of BMS were down 1.1 percent in Thursday morning trading on the New York Stock Exchange. Another Phase III study, CheckMate-548, evaluates Opdivo in combination with radiation and the drug temozolomide in MGMT-methylated GBM patients...
Aug 8, 2018	Preventing Hair Loss During Chemotherapy Is Now Possible, But Insurance Coverage Is Inconsistent	A breast cancer patient wears a scalp cooling device during chemotherapy treatment. Photographer:... [+] Tony Avelar/Bloomberg
Jul 11, 2018	Novartis punts a late-stage PI3K drug with a worrying safety profile to one of China’s upstart biotechs	Just months after a group of researchers warned against the further development of a worrying PI3K inhibitor project Novartis had been working on, the pharma giant licensed out the global rights to a newly active Chinese ...
May 24, 2018	Pfizer executives are changing their tune on an approach for a promising new way to treat cancer, and it could be where the field is headed	NIAID / Flickr A healthy human t-cell is shown in this scanning electron micrograph image. Advertisement We're learning more about how a new class of cancer drugs that targets the body's immune system work in some patients, but no...
May 23, 2018	Right-to-try bill passes in House, heads to president’s desk for signature	The newly-passed bill is a departure from an earlier right-to-try bill that the House passed in March. That version included more safeguards, including greater Food and Drug Administration oversight, stronger reporting requirements and a na...
Jul 20, 2017	Watch: Grappling with cancers like John McCain’s glioblastoma that break all the rules	Arizona Sen. John McCain’s recent diagnosis of the hard-to-treat cancer glioblastoma stands in contrast to recent media reports that paint an optimistic picture of cancer treatment in America. A sampling of headlines includes “Cancer surviv...
May 17, 2017	Blockbuster cancer drug shows surprising promise in treating severe asthma	A blockbuster cancer drug may have a surprising new use: It’s showing real promise in treating severe asthma. That may help researchers better understand the basic biology of the chronic condition — and develop new medications, according to...
Apr 7, 2017	Trial Of Immune Drug In Breast Cancer Points To Need For Biomarkers	Shutterstock
	Right-to-try bill passes in House, heads to president’s desk for signature	The House of Representatives passed a controversial bill Tuesday night that would allow patients with life-threatening illnesses to try experimental treatments while sidestepping federal regulators. Senate Bill 204 – dubbed the Trickett Wen...
	Digital health investment opportunities in 2022	At the dawn of a new year, it seems like the perfect time to reflect on what has been an exciting 12 months of investment in digital health and explore what’s next in 2022. A total of $21.3B was invested between Q1-Q3 of 2021, up from $14.6...
	BMS’s immunotherapy drug Opdivo fails in Phase III brain cancer study	A study conducted by Bristol-Myers Squibb combining its immunotherapy agent with radiation in patients with the most aggressive form of brain cancer has failed, the drugmaker said. New York-based BMS said Thursday that its Phase III CheckMa...

Reviews 0

FAQ about The ASCO Post

What has the press written about The ASCO Post?

Parsers VC has collected 29 articles mentioning The ASCO Post, among them “AstraZeneca Pays $600M for Oral Pill That Beat Chemo in Rare Lung Cancer” (Jul 15, 2026) and “SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform” (Jun 13, 2024).

Is The ASCO Post still active?

Yes, The ASCO Post is active; its latest activity on Parsers VC dates from Nov 5, 2026.